SUBSCRIBE
SUBSCRIBE

Phase III

Bay Area's Dynavax Quietly Shops Around Its Almost-Approved Hep B Vaccine
Drug Development
Death Count Rises for Patients on Dynavax’s Hep B Vaccine But Overall Rate Was Low, Says the FDA
July 26, 2017
 · 
2 min read
Massachusetts’ Histogenics Looks to NeoCart for Replacing Knee Cartilage Loss
Drug Development
Massachusetts’ Histogenics Looks to NeoCart for Replacing Knee Cartilage Loss
July 25, 2017
 · 
3 min read
How Eli Lilly Allegedly Used a Fake Rule and Fake News to Protect Bad Patents
Drug Development
Eli Lilly Shakes Up Cancer R&D Strategy, Seeks New Home for Seven Pipeline Drugs
July 25, 2017
 · 
3 min read
Merck & Co.'s Alzheimer's Contender Wows in Human Clinical Trial
Drug Development
Merck & Co. Dealt Another Setback as Its Ace Keytruda Comes Up Short in Head and Neck Cancer Study
July 25, 2017
 · 
3 min read
Drug Development
Data Put A Dent In Ironwood’s Expansion Plans
July 24, 2017
 · 
1 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
5 Biotechs With $45 Billion Worth of Not-Yet Approved Drugs in the Pipeline
July 24, 2017
 · 
3 min read
3 Biotechs That Could be Taken Out This Quarter
Drug Development
2 Tiny Cancer Biotechs That Could Gain Steam by Year-End
July 24, 2017
 · 
3 min read
10 Biotechs Tackling Senator John McCain's Form of Aggressive Brain Cancer
Drug Development
10 Biotechs Tackling Senator John McCain’s Form of Aggressive Brain Cancer
July 21, 2017
 · 
3 min read
Kite Pharma's CAR-T Blood Cancer Candidate Succeeds in Major Study
Drug Development
Kite Pharma Touts Remissions Up to 56+ Months in Non-Hodgkin Lymphoma Patients on CAR T-Cell Therapy
July 20, 2017
 · 
3 min read
Drug Development
Genentech R&D Exec Reveals Alzheimer’s is Still A Priority
July 19, 2017
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Idorsia to present long-term lucerastat data and kidney biopsy results at WORLDSymposium
January 30, 2026
 · 
9 min read
Press Releases
Quince Therapeutics Announces Topline Results from Pivotal Phase 3 NEAT Clinical Trial of eDSP in Ataxia-Telangiectasia
January 30, 2026
 · 
6 min read
Press Releases
Regentis Expanding Pivotal Phase III GelrinC Clinical Site Network: Adding Several Leading Orthopedic Centers Across the U.S.
January 29, 2026
 · 
7 min read
Press Releases
Ascletis Announces Positive Topline Results from Its Phase III Open-Label Study of Denifanstat (ASC40), a First-in-Class, Once-Daily Oral FASN Inhibitor for Acne
January 29, 2026
 · 
3 min read
Press Releases
Aicuris Announces Pritelivir Phase 3 HSV Data to Be Presented as Late-Breaking Oral Presentation at Tandem
January 29, 2026
 · 
2 min read
Press Releases
Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZI™, the First and Only Combination Eye Drop Approved to Treat Presbyopia
January 29, 2026
 · 
8 min read
Press Releases
First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA
January 29, 2026
 · 
6 min read
Press Releases
Ensysce Biosciences Provides Enrollment Update on Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid for Severe Acute Pain
January 29, 2026
 · 
4 min read
Press Releases
OKYO Pharma Announces Successful Type C Meeting with the FDA
January 29, 2026
 · 
5 min read
Press Releases
Baseline Therapeutics Launches to Advance GLP-1RA Phase 3 Program in Alcohol Use Disorder
January 28, 2026
 · 
3 min read
Press Releases
Bayer to Present Results From Phase III OCEANIC-STROKE Study of Asundexian in Secondary Stroke Prevention
January 28, 2026
 · 
4 min read
Press Releases
Cloudbreak Pharma Announces Successful End-of-Phase-2 Meeting and Alignment with FDA on Phase 3 Path Forward for CBT-004
January 28, 2026
 · 
7 min read
Press Releases
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE-2 Phase 3 Clinical Trial in ATTRv-PN
January 28, 2026
 · 
6 min read
Press Releases
Sarepta Announces Positive Topline Three-Year EMBARK Results Showing ELEVIDYS Significantly Slows Disease Progression on Key Functional Measures in Ambulatory Duchenne Patients
January 27, 2026
 · 
16 min read
Press Releases
Scancell announces FDA clearance of IND application for global Phase 3 trial of iSCIB1+ in advanced melanoma
January 26, 2026
 · 
4 min read
Press Releases
Bausch Health Provides Update on RED-C Phase 3 Clinical Trials
January 26, 2026
 · 
3 min read
Press Releases
Vaxcyte Advances Adult and Infant Programs for VAX-31, a Potential Best-in-Class, Next-Generation Pneumococcal Conjugate Vaccine
January 23, 2026
 · 
17 min read
Press Releases
Overall Survival Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer
January 23, 2026
 · 
7 min read
Press Releases
New England Journal of Medicine Publishes Phase 3 ASCENT-04/KEYNOTE-D19 Results Supporting Trodelvy® Plus Keytruda® as a Potential New Standard of Care in First-line PD-L1+ Metastatic Triple-negative Breast Cancer
January 22, 2026
 · 
17 min read
Press Releases
IntraBio Announces Positive Pivotal Trial Results of Levacetylleucine for the Treatment of Ataxia-Telangiectasia
January 21, 2026
 · 
5 min read
Load More